ArticleJournal of ultrasound2026
Evaluating the correlation of intestinal ultrasound and fecal calprotectin with endoscopic severity scores in assessing disease activity in ulcerative colitis patients.
Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsUlcerative colitis (UC) is a chronic inflammatory bowel disease. Noninvasive markers, including fecal calprotectin (FC) and intestinal ultrasound (IUS), have emerged as promising tools for assessing UC activity. To establish the correlation between noninvasive test IUS and fecal calprotectin with the gold standard invasive test UCEIS for assessing disease activity in patients with UC. MATERIALS AND
methodsSixty UC patients were enrolled, and comprehensive demographic, clinical, and biochemical data were collected. FC levels, IUS findings, UCEIS scores, and endoscopic Mayo scores were analyzed.
resultsA significant correlation was noted in between fecal calprotectin and bowel wall thickness (BWT) in descending colon (r = 0.423, p = 0.001) and the rectosigmoid (r = 0.306, p = 0.017). Further strong positive correlation was observed between UCEIS and BWT in the descending colon (r = 0.653, p = 0.001) and rectosigmoid (r = 0.406, p = 0.001). The combination of BWT > 3 mm or FC > 250 μg/g demonstrated high sensitivity (92.3%) for detecting active disease, while higher cutoffs showed improved specificity. These findings suggest that IUS and FC may serve as reliable noninvasive tools for assessing disease activity in moderate-to-severe UC. In contrast, the combination of BWT > 4 mm or FC > 500 demonstrated lower sensitivity (68.9%) but increased specificity (94.2%), making it a more precise but less sensitive indicator.
conclusionFC and IUS offer valuable insights into disease activity and may complement endoscopic evaluation. Early utilization of IUS with FC pre- and post-treatment initiation accurately correlates well with endoscopic disease activity and improvement in moderate-to-severe UC, suggesting their potential as diagnostic and prognostic tools for close monitoring and treatment optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.